SCHEMBL24467136

SCHEMBL24467136

CC(C)CN(CC1CCCN1)C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 14/20 0.36
▸ CYP2D6 P10635 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ MLNR O43193 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12339290 0.80 GHSR (0.36) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL13309419 0.79 GHSR (0.36) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL21165727 0.76 GHSR (0.38) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL12102102 0.76 GHSR (0.38) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL12339291 0.75 SLC6A2 (0.41) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL27010030 0.75 GHSR (0.41) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL27010028 0.75 GHSR (0.41) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL13309421 0.74 SLC6A2 (0.40) GHSRCYP2D6MEN1ALDH1A1LMNA
SCHEMBL17914488 0.71 ALOX5 (0.32) —
SCHEMBL12855097 0.71 CYP2D6 (0.38) GHSRCYP2D6MEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3534899-B1 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS INC (US) 2022-06-01 — — EP disclosed
Send feedback